Perugia Consensus Conference on Antiemetic Therapy

In the last decade, important progress has been achieved in the prevention of chemotherapy-induced nausea and vomiting, in particular since the introduction of 5-HT3 antagonists which, when used in combination with steroids, can assure significant protection in the majority of patients. Nonetheless, for some relevant clinical problems there still is no satisfactory answer, and there are major differences in clinical practice regarding antiemetic use. This volume contains the results of the fifth Perugia International Cancer Conference which was organized in 8 sessions, a consensus document was prepared for each session forming a useful basis for future developments.
TOC: From the Contents: Corticosteroids, Dopaine Antagonists and other Drugs.- Optimal Selection of Antiemetics in Children Receiving Cancer Chemotherapy.- Methodology of Antiemetic Trials: Response Assessment, Evaluation of New Agents and Definition of Chemotherapy Emetogenicity.- Delayed Emesis Following Anticancer Therapy.- Antiemetic Strategies for 5HT3 antagonists in the Prevention of Acute Emesis Induction by Moderately to Highly Emetogenetic Chemotherapy Dose, Schedule, and Route of Administration.- The Aetiology and Prevention of Emesis Induced by Radiotherapy.-